Flagstar Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Flagstar Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,826	Closed	-$235K	–	168
2023 Q2	$235K	Sell	2,826 -2,280	-45%	-$191K	0.09%	145
2023 Q1	$389K	Sell	5,106 -402	-7%	-$33.4K	0.14%	118
2022 Q4	$457K	Sell	5,508 -415	-7%	-$33.6K	0.16%	106
2022 Q3	$470K	Buy	5,923 +1,903	+47%	+$160K	0.18%	107
2022 Q2	$298K	Buy	4,020 +290	+8%	+$21.8K	0.11%	125
2022 Q1	$335K	Buy	3,730 +1,327	+55%	+$123K	0.11%	121
2021 Q4	$269K	Sell	2,403 -389	-14%	-$46.9K	0.08%	124
2021 Q3	$351K	Buy	+2,792	New	+$360K	0.12%	107

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Flagstar Advisors's XBI Position: Q3 2023 in Review

Flagstar Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 2,826 shares — an estimated $235K sold.

Flagstar Advisors first reported a position in XBI in Q3 2021 and held it in 8 quarters. The position peaked at $470K in Q3 2022. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Flagstar Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
Flagstar Advisors sold 2,826 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $235K.
Flagstar Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and held it in 8 quarters.
Flagstar Advisors's State Street SPDR S&P Biotech ETF position peaked at $470K in Q3 2022.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Flagstar Advisors's 13F filing for Q3 2023, filed 18 Oct 2023.